LCN2 and colitis: Male Tacr2−/− mice were protected from the deleterious effects of induced colitis, exhibiting attenuated weight loss, reduced plasma and fecal lipocalin-2 (LCN2) concentration (a marker of intestinal inflammation49), ameliorated histopathology with preserved architecture and less immune-cell infiltration.